Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-10-28
1997-11-18
Stone, Jacqueline M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
424 931, 424 9321, 4351723, 4352401, 4352402, 43524025, 4353201, A61K 4800, C12N 500, C12N 1500, C07N 1400
Patent
active
056887736
ABSTRACT:
A method for selectively killing nervous system and peripheral neoplastic cells is provided. Viral vectors are used to selectively express a cytochrome P450 gene in neoplastic cells, whose gene product targets the cells for selective killing, by rendering the cells sensitive to a chemotherapeutic agent.
REFERENCES:
Marshall, Science 269:1050-1055, 1995.
Culver et al., Trends Genetics, 10(5):174-178, 1994.
Miller et al., FASEB Journal, 9;190-199, 1995.
Hodgson et al., Exp. Opin. Ther. Pat. 5(5):459-468, 1995.
Orkin et al. "Report and Recommendations . . . " Dec. 7, 1995, 1-40.
LaFont et al., Lancet 346:1442-1443, 1995.
Gutierrez et al, Gene Therapy for Cancer, The Lancet, vol. 339: Mar. 21, 1992 pp. 715-721.
Friedmann, T., Gene Therapy of Cancer Through Restoration of Tumor-Suppressor Functions, Cancer, vol. (6) 70, Sep. 15, 1992.
Culver et al, Science, vol. 256, 12, Jun. 1992 pp. 1550-1552.
Weber et al, Biochemical Pharmacology, vol. 45, 1993 pp. 1685-1694.
Manome et al, Cancer Research, 54, 5408-5413 Oct. 15, 1994.
Amano et al., "High Activity of Choline Acetyltransferase Induced in Neuroblastoma x Glia Hybrid Cells," Exp. Cell Res. 85:399-408 (1974).
Angier, N. "Tumor Treatment Showing Promise," N.Y. Times, National Edition, p. B11 (Sep. 8, 1993).
Araki et al., "The Essential Region for Assembly and Particle Formation in Hepatitis B Virus Surface Antigen Produced in Yeast Cells," Gene 89:195-201 (1990).
Arndt et al., "Intrathecal Administration of 4-Hydroperoxycyclophosphamide in Rhesus Monkeys," Cancer Res. 47:5932-5934 (1987).
Austin, F.C. and Boone, C.W., "Virus Augmentation of the Antigenicity of Tumor Cell Extracts," Adv. Cancer Res. 30:301-345 (1979).
Baker et al., "Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53," Science 249:912-915 (1990).
Barba et al., "Development of anti-tumor immunity following thymididine kinase-mediated killing of experimental brain tumors," PNAS USA 91:4348-4352 (1994).
Barker et al., "Cloning and Sequence Analysis of the Human Gene Encoding Eosinophil Major Basic Protein," Gene 86:285-289 (1990).
Barker et al., "Development of an Animal Brain Tumor Model and Its Response to Therapy with 1,3-Bis(2-chlorethyl-1-nitrosourea," Cancer Res. 33:976-983 (1973).
Beerman, W.F., "Meningeal Carcinomatosis," JAMA 58(19):1437-1439 (1912).
Benda et al., "Differentiated Rat Glial Cell Strain in Tissue Culture," Science 161:370-371 (1968).
Benda et al., "Morphological and immunochemical studies of rat glial tumors and clonal strains propagated in culture," J. Neurosurg. 34:310-323 (1971).
Bennett, J.E., "Antimicrobial Agents: Antifungal Agents," in: Goodman and Gilman's The Pharmacological Basis of Therapeutics, Gilman et al., eds., vol. 8, Pergamon Press: NY, NY, pp. 1165-1181 (1990).
Berends et al., "The Detection of Virally Induced Tumors by .sup.131 I-and .sup.125 I-Labeled Syngeneic Monoclonal Antibodies," Cancer Immunol. Immunother. 26:243-249 (1988).
Bernstein, A. and Breitman, M., "Genetic Ablation in Transgenic Mice," Mol. Biol. Med. 6:523-530 (1989).
Bignami et al., "Localization of the Glial Fibrillary Acidic Protein in Astrocytes by Immunofluorescence," Brain Res. 43:429-435 (1972).
Bigner et al. "Patterns of the Early, Gross Chromosomal Changes in Malignant Human Gliomas," Hereditas 101:103-113 (1984).
Bigner et al., "Specific Chromosomal Abnormalities in Malignant Human Gliomas," Cancer Res. 88:405-411 (1988).
Borrelli et al., "Transgenic Mice with Inducible Dwarfism," Nature 339:538-541 (1989).
Boviatsis et al., "Gene Transfer into Experimental Brain Tumors Mediated by Adenovirus, Herpes Simplex Virus, and Retrovirus Vectors," Human Gene Ther. 5:183-191 (1994).
Breakefield, X.O. and Geller, A.I., "Gene Transfer into the Nervous System," Molec. Neurobiol. 1:339-371 (1987).
Brem et al., "Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain," J. Neurosurg. 80:283-290 (1994).
Burger et al., "Computerized tomographic and pathologic studies of the untreated quiescent, and recurrent glioblastoma multiforme," J. Neurosurg. 58:159-169 (1983).
Burns et al., "Vesicular Stomatitis Virus G Glycoprotein Pseudotyped Retroviral Vectors: Concentration to Very High Titer and Efficient Gene Transfer Into Mammalian and Nonmammalian Cells," PNAS USA 90:8033-8037 (1993).
Capecchi, M.R., "The New Mouse Genetics: Altering the Genome by Gene Targeting," TIG 5(3):70-76 (1989).
Caruso et al., "Regression of Established Macroscopic Liver Metastases After In Situ Transduction of a Suicide Gene," PNAS USA 90:7024-7028 (1993).
Cepko, C., "Immortalization of Neural Cells via Retrovirus-Mediated Oncogene Transduction," Ann. Rev. Neurosci. 12:47-65 (1989).
Cepko, C., "Lineage Analysis and Immortalization of Neural Cells via Retrovirus Vectors," in: Neuromethods, vol. 16, Molecular Neurobiological Techniques, Bolton et al., eds., Clifton, NJ, Humana, pp. 177-219 (1989).
Cepko et al., "Preparation of a Specific Retrovirus Producer Cell Line," in: Current Protocols in Molec. Biol., Ausubel et al., eds., Wiley and Sons, NY, pp. 9.11.1-9.11.12 (1992).
Chana, T.K.H. and Waxman, D.J., "Cyclophosphamide Modulates Rat Hepatic Cytochrome P450 2C11 and Steroid 5.alpha.-Reductase Activity and Messenger RNA Levels through the Combined Action of Acrolein and Phosphoramide Mustard," Cancer Res. 53:2490-2497 (1993).
Chang et al., "Differential Activation of Cyclophosphamide and Ifosphamide by Cytochromes P-450 2B and 3A in Human Liver Microsomes," Cancer Res. 53:5629-5637 (1993).
Chang et al., "Evaluation of Triacetyloleandomycin, .alpha.-Naphthoflavone and Diethyldithiocarbamate as Selective Chemical Probes for Inhibition of Human Cytochromes P450," Arch. Biochem. Biophys. 311(2):437-442 (1994).
Cheng et al., "Photoradiation Therapy: Current Status and Applications in the Treatment of Brain Tumors," Surg. Neurol. 25:423-435 (1986).
Chiocca et al., "Virus-Mediated Genetic Treatment of Rodent Gliomas," in: Gene Therapeutics, Wolff, J.A., ed., Birkhauser Publ., Boston, MA, pp. 245-262 (1994).
Clarke, L. and Waxman, D.J., "Oxidative Metabolism of Cyclophosphamide: Identification of the Hepatic Monooxygenase Catalysts of Drug Activation," Cancer Res. 49:2344-2350 (1989).
Coen et al., "A Genetic Approach to Promoter Recognition During trans Induction of Viral Gene Expression," Science 234:53-59 (1986).
Coen et al., "Thymidine Kinase-Negative Herpes Simplex Virus Mutants Establish Latency in Mouse Trigeminal Ganglia but do not Reactivate," PNAS USA 86:4736-4740 (1989).
Colvin, M., "Alkylating Agents and Platinum Antitumor Compounds," in: Cancer Medicine, Holland et al., eds., Lea and Febiger, Philadelphia, PA, pp. 733-754 (1993).
Colvin, M. and Hilton, J. "Pharmacology of Cyclophosphamide and Metabolites," Cancer Treat. Rep. 65 (Suppl. 3):89-95 (1981).
Cone, R.D. and Mulligan, R.C., "High-efficiency gene transfer into mammalian cells: Generation of helper-free recombinant retrovirus with broad mammalian host range," PNAS USA 81:6349-6353 (1984).
Corey et al., "Infections With Herpes Simplex Viruses, Part I," New Engl. J. Med. 314(11):686-691 (1986).
Corey et, al., "Infections With Herpes Simplex Viruses, Part II," New Engl. J. Med. 314(12):749-757 (1986).
Cox, P.J., "Cyclophosphamide Cystitis--Identification of Acrolein as the Causative Agent," Biochem. Pharmacol. 28:2045-2049 (1979).
Culver et al., "In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors," Science 256:1550-1552 (1992).
Danos, O. and Mulligan, R.C., "Safe and Efficient Generation of Recombinant Retroviruses with Amphotropic and Ecotropic Host Ranges," PNAS USA 85:6460-6464 (1988).
Das, G.D. and Altman, J., "Postnatal neurogenesis in the caudate nucleus and nucleus accumbens septi in the rat," Brain Res. 21:122-127 (1970).
Daumas-DuDort et al. "Grading of Astrocytomas, A Simple and Reproducible Method," Cancer 62(10):2152-2165 (1988).
Doehmer et al., "Genetically Engineered V79 Chinese Hamster Cells Metabolically Activate the Cytostatic Drugs Cyclophosphamide and Ifosfamide," Environ. Health Perspec
Breakefield Xandra O.
Chen Ling
Chiocca E. Antonio
Waxman David J.
Wei Ming X.
Boston University
Dana-Farber Cancer Institute
Milne Andrew
Stone Jacqueline M.
The General Hospital Corporation
LandOfFree
Method of selectively destroying neoplastic cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of selectively destroying neoplastic cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of selectively destroying neoplastic cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1565684